Episode 24042
Replacing Cells, Restoring Sight…Brian Culley, CEO, Lineage Cell Therapeutics
BioTech Nation ... with Dr. Moira Gunn · Moira Gunn
October 16, 202416m 4s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Brian Culley, CEO of Lineage Cell Therapeutics, talks about a new approach to treating diseases called whole cell replacement therapy - which replaces damaged cells with new ones. Lineage is focusing this new therapy on dry age-related macular degeneration (AMD), a leading cause of blindness, through their collaboration with Genentech..
Topics
Cell replacement therapydry age-related macular degeneration (AMD)vision restorationretinal cellsLineage Cell TherapeuticsGenentech collaborationgeographic atrophyblindness treatmentophthalmologyclinical trialswhole cell therapyregenerative medicine